Updates
Drug May Be First Non-Opioid Treatment for Infant Withdrawal
More than 30,000 babies a year are born in the United States with neonatal opioid withdrawal syndrome, yet treatment options are limited to supportive care or medicating with more opiates, such as morphine. In a new clinical trial, Stanford Medicine researchers found...
Justice Department Awards More Than $340 Million to Address Substance Use Disorders and Fight the Overdose Epidemic
The Department of Justice’s Office of Justice Programs (OJP) recently announced grant awards totaling more than $340 million to help combat America’s substance use crisis amid a continued escalation of overdose deaths. Opioids – particularly synthetic drugs like...
Advocates Say President Biden’s Pot Pardon Will Help Reverse War on Drugs Harm to Black People
President Biden recently announced an executive order to pardon federal, simple marijuana possession charges for thousands of Americans – an important first step, advocates say, to reversing decades of uneven drug enforcement policy that has historically burdened...
Guide to Providing Medication for Opioid Use Disorder (MOUD) through Office-Based Opioid Treatment (OBOT) Programs
A Duke Opioid Collaboratory project has released a guide to providing medication for opioid use disorder (MOUD) through office-based opioid treatment (OBOT) programming at local health departments or other primary care clinics. This guide was developed in a...
Transforming Management of Opioid Use Disorder with Universal Treatment
Barriers at multiple levels impede the use of evidence-based medication for opioid use disorder. Actions by clinicians, health care systems, and policymakers could substantially expand treatment access. This article notes that only a small percentage of people with...
Growing Public Health Concern: Unintentional Ingestion of Edible Cannabis in Toddlers
THC-infused edibles such as gummies resemble children’s candy and inappropriate storage places young children at risk of ingestion and toxic effects. In this viewpoint, the authors call for immediate action to change the current trajectory of unintentional pediatric...
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.